Assessing the PK of Met DR, Met IR, and Met XR in Healthy Subjects
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
This study compared the pharmacokinetics (PK) and assessed the safety of delayed-release
metformin (Met DR, EFB0027) at two dosage levels, immediate-release metformin (Met IR,
ETB0015), and extended-release metformin (Met XR, ETB0014) in healthy subjects.